New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
06:54 EDTGSKGSK says curruption base 'deeply concerning,' Reuters says
GlaxoSmithKline said that it is taking the China corruption charges "very seriously" and feels that the case is "deeply concerning," according to Reuters, citing a brief statement from the pharmaceutical company. Reference Link
News For GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 6, 2015
08:57 EDTGSKGlaxoSmithKline return of transaction net proceeds to be reduced to GBP1B
Subscribe for More Information
07:32 EDTGSKGlaxoSmithKline cost savings program to be accelerated
Subscribe for More Information
07:31 EDTGSKGlaxoSmithKline to retain existing holding in ViiV Healthcare
GSK announced the decision has been taken to retain existing holding in ViiV Healthcare reflecting updated strong positive outlook.
07:30 EDTGSKGlaxoSmithKline sees FY15 core EPS down high teens percentage
2015 core EPS expected to decline at a percentage rate in the high teens, CER, primarily due to continued pricing pressure on Advair in US/Europe, the dilutive effect of the transaction and inherited cost base of the Novartis businesses. Significant recovery anticipated in 2016 with core EPS percentage growth expected to reach double digits, CER.
07:29 EDTGSKGlaxoSmithKline sees core EPS to grow mid-to-high single digit CAGR in 2016-2020
Subscribe for More Information
07:28 EDTGSKGlaxoSmithKline reports Q1 adjusted EPS 17.3p, consensus 17.4p
Reports Q1 core sales of GBP5.6B, consensus GBP5.65B.
05:48 EDTGSKViiV Healthcare begins Phase III trial with dolutegravir/rilpivirine combination
Subscribe for More Information
May 5, 2015
15:02 EDTGSKNotable companies reporting before tomorrow's open
Subscribe for More Information
09:31 EDTGSKGlaxoSmithKline, partners make EU submission for gene therapy to treat ADA-SCID
Subscribe for More Information
May 3, 2015
18:11 EDTGSKSiemens investigated by Chinese regulator last year, Reuters says
Subscribe for More Information
May 1, 2015
07:43 EDTGSKExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
April 30, 2015
16:59 EDTGSKGlaxoSmithKline, Theravance announce FDA approval of Breo Ellipta
Subscribe for More Information
15:20 EDTGSKGlaxo says FDA issued CRL on use of Breo Ellipta in patients aged 12-17
Subscribe for More Information
15:17 EDTGSKGlaxoSmithKline says FDA approves BREO ELLIPTA for adults with asthma
GlaxoSmithKline (GSK) and Theravance (THRX) announced that the FDA has approved BREO ELLIPTA for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is not indicated for the relief of acute bronchospasm. Breo is a fixed-dose combination of the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist vilanterol. Two strengths, 100/25mcg and 200/25mcg, have been approved in the US for use in asthma, administered once-daily using the Ellipta dry powder inhaler.
07:21 EDTGSKFDA PDUFA Date for Theravance BREO ELLIPTA is April 30, 2015
April 27, 2015
10:04 EDTGSKHigh option volume stocks
Subscribe for More Information
08:46 EDTGSKAgenus data positive, says JMP Securities
Subscribe for More Information
08:41 EDTGSKTelegraph discusses potential takeover of GSK by Pfizer
Subscribe for More Information
06:19 EDTGSKPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 24, 2015
07:11 EDTGSKAgenus: GSK's RTS,S vaccine showed statistically significant results in study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use